• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性心脏病患者中的新冠肺炎:我们学到了什么?

COVID-19 in congenital heart disease patients: what did we learn?!

作者信息

Zareef Rana, Salameh Elio, Hammoud Rawan, Tannouri Theresia, Bitar Fadi, Arabi Mariam

机构信息

Pediatric and Adolescent Medicine Department, American University of Beirut Medical Center, Beirut, Lebanon.

Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

出版信息

Front Cardiovasc Med. 2023 Aug 31;10:1235165. doi: 10.3389/fcvm.2023.1235165. eCollection 2023.

DOI:10.3389/fcvm.2023.1235165
PMID:37719985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10501459/
Abstract

AIM

COVID-19 pandemic has spread widely at unpreceded pace. Cardiovascular comorbidities are significantly correlated with severe and critical illness. Nevertheless, studies examining the impact of congenital heart disease on COVID-19 severity are scarce and restricted to hospitalized patients. This study aims to explore the course of COVID-19 illness, severity and complications in patients with concomitant congenital heart disease.

METHODOLOGY

This study is a cross sectional survey that includes patients with congenital heart disease who are registered at the Children Heart Center at the American University of Beirut Medical Center. The survey was conducted in the pediatric cardiology outpatient clinics or remotely via phone calls.

RESULTS

A total of 238 patients participated in the study, of which 47.9% had suspected or confirmed diagnosis of SARS-CoV-2 infection. The majority of patients had mild illness. The symptoms ranged between rhinorrhea (15.6%), cough (15.6%), low-grade fever (11.2%), anosmia (2.7%), ageusia (2.5%), headache (9.8%), high-grade fever (8.5%), gastrointestinal symptoms (7.6%), lethargy (6.3%), muscle aches (5.6%), difficulty breathing (5.4%), joint pain (4.7%), and chills (4.7%). 20% of the surveyed patients required treatment at home. Hospitalization and oxygen therapy was required in 3.5% of cases, while only 1.5% demanded intensive care admission. Only one fatality was encountered.

CONCLUSION

COVID-19 infection in pateints with congenital heart disease exhibits a mild to moderate course, and doesn't necessarily increase risk of complicated disease. No correlation could be found between specific congenital heart lesion and disease severity.

摘要

目的

新冠疫情以前所未有的速度广泛传播。心血管合并症与重症和危重症显著相关。然而,关于先天性心脏病对新冠严重程度影响的研究较少,且仅限于住院患者。本研究旨在探讨合并先天性心脏病患者的新冠病程、严重程度及并发症。

方法

本研究为横断面调查,纳入了在贝鲁特美国大学医学中心儿童心脏中心登记的先天性心脏病患者。调查在儿科心脏病门诊进行,或通过电话远程开展。

结果

共有238名患者参与研究,其中47.9%疑似或确诊感染了SARS-CoV-2。大多数患者病情较轻。症状包括流涕(15.6%)、咳嗽(15.6%)、低热(11.2%)、嗅觉减退(2.7%)、味觉减退(2.5%)、头痛(9.8%)、高热(8.5%)、胃肠道症状(7.6%)、嗜睡(6.3%)、肌肉酸痛(5.6%)、呼吸困难(5.4%)、关节疼痛(4.7%)和寒战(4.7%)。20%的被调查患者需要在家治疗。3.5%的病例需要住院和吸氧治疗,而只有1.5%的患者需要入住重症监护病房。仅出现1例死亡。

结论

先天性心脏病患者的新冠感染表现为轻至中度病程,不一定会增加并发症风险。未发现特定先天性心脏病病变与疾病严重程度之间存在关联。

相似文献

1
COVID-19 in congenital heart disease patients: what did we learn?!先天性心脏病患者中的新冠肺炎:我们学到了什么?
Front Cardiovasc Med. 2023 Aug 31;10:1235165. doi: 10.3389/fcvm.2023.1235165. eCollection 2023.
2
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.社区人群中与新型冠状病毒感染相关的症状和症状群:一项全州范围流行病学研究的结果
medRxiv. 2020 Oct 22:2020.10.11.20210922. doi: 10.1101/2020.10.11.20210922.
5
Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.羟氯喹预防 SARS-CoV-2 感染和妊娠期 COVID-19 疾病严重程度的疗效和安全性(COVID-Preg):一项随机安慰剂对照试验研究方案的结构化总结。
Trials. 2020 Jul 2;21(1):607. doi: 10.1186/s13063-020-04557-y.
6
Clinical characteristics and outcomes of children with COVID-19 in Saudi Arabia.沙特阿拉伯新冠肺炎儿童患者的临床特征与转归
Saudi Med J. 2021 Apr;42(4):391-398. doi: 10.15537/smj.2021.42.4.20210011.
7
[Treatment setting, symptomatology, clinical course, severity degree and case-fatality rate in 536 adults over 50 years with laboratory-confirmed COVID-19 in Tarragona, Spain, March-June 2020.].[2020年3月至6月西班牙塔拉戈纳536名50岁以上实验室确诊的成人新冠肺炎患者的治疗环境、症状、临床病程、严重程度和病死率。]
Rev Esp Salud Publica. 2021 Sep 8;95:e202109115.
8
A Study of Symptomatology of COVID-19 Laboratory-Confirmed Cases at Tertiary Care Center: A Cross-Sectional Study.三级医疗中心新冠病毒实验室确诊病例症状学研究:一项横断面研究。
Cureus. 2022 Feb 13;14(2):e22186. doi: 10.7759/cureus.22186. eCollection 2022 Feb.
9
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
10
Data from the first wave of Covid-19 from the Central Military Hospital, Prague, Czech Republic.来自捷克布拉格中央军事医院的第一波新冠疫情数据。
Epidemiol Mikrobiol Imunol. 2020 Winter;69(4):164-171.

引用本文的文献

1
Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis.儿科危重症 COVID-19 的危险因素:系统评价和荟萃分析。
J Pediatric Infect Dis Soc. 2024 Jul 20;13(7):352-362. doi: 10.1093/jpids/piae052.
2
Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce.儿童和青少年 COVID-19 预防和管理指南:儿科传染病学会儿科 COVID-19 治疗工作组的共识声明。
J Pediatric Infect Dis Soc. 2024 Mar 19;13(3):159-185. doi: 10.1093/jpids/piad116.
3
Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis.

本文引用的文献

1
COVID-19 Infections in Adults with Congenital Heart Disease-A Prospective Single-Center Study in an Outpatient Setting.先天性心脏病成人患者的新冠病毒感染——一项门诊环境下的前瞻性单中心研究
J Clin Med. 2022 Oct 17;11(20):6105. doi: 10.3390/jcm11206105.
2
Outcome of COVID-19-positive children with heart disease and grown-ups with congenital heart disease: A multicentric study from India.新冠病毒检测呈阳性的患心脏病儿童及患先天性心脏病成人的预后:一项来自印度的多中心研究。
Ann Pediatr Cardiol. 2021 Jul-Sep;14(3):269-277. doi: 10.4103/apc.apc_134_21. Epub 2021 Aug 26.
3
Worse Hospital Outcomes for Children and Adults with COVID-19 and Congenital Heart Disease.
儿童重症 COVID-19 的危险因素:系统评价与荟萃分析
medRxiv. 2024 Jan 18:2024.01.17.24301452. doi: 10.1101/2024.01.17.24301452.
COVID-19 合并先天性心脏病患儿和成人的预后更差。
Pediatr Cardiol. 2022 Mar;43(3):541-546. doi: 10.1007/s00246-021-02751-6. Epub 2021 Oct 11.
4
Cardiac Manifestations in COVID-19 Patients: A Focus on the Pediatric Population.COVID-19患者的心脏表现:聚焦儿科人群
Can J Infect Dis Med Microbiol. 2021 Jul 16;2021:5518979. doi: 10.1155/2021/5518979. eCollection 2021.
5
COVID-19 in Adults With Congenital Heart Disease.成人先天性心脏病患者中的 COVID-19。
J Am Coll Cardiol. 2021 Apr 6;77(13):1644-1655. doi: 10.1016/j.jacc.2021.02.023.
6
Clinical outcome of COVID-19 in patients with adult congenital heart disease.成人先天性心脏病患者感染新型冠状病毒肺炎的临床结局
Heart. 2021 Jul 12;107(15):1226-1232. doi: 10.1136/heartjnl-2020-318467.
7
COVID-19 and congenital heart disease: a case series of nine children.COVID-19 与先天性心脏病:9 例患儿的病例系列。
World J Pediatr. 2021 Feb;17(1):71-78. doi: 10.1007/s12519-020-00397-7. Epub 2021 Jan 2.
8
Impact of Coronavirus Disease 2019 (COVID-19) on Patients With Congenital Heart Disease Across the Lifespan: The Experience of an Academic Congenital Heart Disease Center in New York City.2019 年冠状病毒病(COVID-19)对全生命周期先天性心脏病患者的影响:纽约市一家学术先天性心脏病中心的经验。
J Am Heart Assoc. 2020 Dec;9(23):e017580. doi: 10.1161/JAHA.120.017580. Epub 2020 Oct 14.
9
COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?COVID-19:我们是否正在应对一种伪装成病毒感染的多系统血管病?
J Thromb Thrombolysis. 2020 Oct;50(3):567-579. doi: 10.1007/s11239-020-02210-8.
10
COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey.新冠病毒肺炎与先天性心脏病:一项全国性调查结果
J Clin Med. 2020 Jun 8;9(6):1774. doi: 10.3390/jcm9061774.